genome editing

GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Ideaya
GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Ideaya
Fierce Biotech
GSK
cancer
R&D
oncology
Ideaya
genome editing
Flag link:
In its first use inside the human body, CRISPR genome editing tested as blindness therapy
In its first use inside the human body, CRISPR genome editing tested as blindness therapy
Stat
gene therapy
blindness
CRISPR
genome editing
Flag link:
Inscripta pushes funding to $260 million as they launch genome editing platform
Inscripta pushes funding to $260 million as they launch genome editing platform
Endpoints
Inscripta
genome editing
synthetic biology
Flag link:
Genome editing company Precision proposes $100M IPO
Genome editing company Precision proposes $100M IPO
BioCentury
genome editing
Precision Biosciences
IPOs
Flag link:
CRISPR identifies genes that might be targeted to hobble HIV infection
CRISPR identifies genes that might be targeted to hobble HIV infection
Stat
CRISPR-Cas9
HIV
genome editing
Flag link:
In CRISPR patent case, all eyes turn to the judge, a former scientist
In CRISPR patent case, all eyes turn to the judge, a former scientist
Stat
patents
CRISPR
genome editing
Intellia Therapeutics
Editas Medicine
CRISPR Therapeutics
Flag link:
Six Themes to Watch at Next Week's Big Human Genetics Event
Six Themes to Watch at Next Week's Big Human Genetics Event
Forbes
Human Genetics
genetics
genome editing
Flag link:
Novartis moves into genome editing with collaboration deal
Novartis moves into genome editing with collaboration deal
Seeking Alpha
Novartis
genome editing
Intellia Therapeutics
Caribou Biosciences
Flag link: